Cervical Screening-1 (Conventional PAP & HPV-DNA) - Smear & LBC

The substance measured in cervical screening-1 includes the detection of human papillomavirus (HPV) DNA and abnormal cells in the cervix. HPV is a common sexually transmitted infection, with some types linked to cervical cancer.

The screening helps to:

• Detect and monitor early signs of cervical cancer
• Evaluate the effectiveness of treatment
• Assess the risk of developing cervical cancer
• Identify HPV DNA, a virus linked to cervical cancer

The screening is recommended for those who have:

• Previous diagnosis or family history of cervical cancer
• Symptoms like abnormal vaginal bleeding
• Women aged 21 to 65 years

If the screening results are found to be abnormal then:

• The results may suggest precancerous changes or HPV infection
• Further testing or treatments may be needed
• Consult your doctor for interpretation and next steps

During the test, you will:

• Undergo a pap smear for cell examination
• Have a sample collected for HPV DNA testing
• May feel minimal discomfort during sample collection

To prepare for the Cervical Screening-1 test, you must -

• Avoid vaginal douches or sexual intercourse 48 hours before the test
• Don't schedule during your menstrual period
• Follow any additional instructions provided by your healthcare provider

Other tests include:

• Colposcopy: Examination of the cervix using a magnifying instrument.
• Endocervical Curettage: Sampling cells from within the cervix
• HPV Genotyping Assay: Identifies specific HPV types present

Pap Smear Test or HPV Screening

Cervical cancer is a type of cancer that develops in the cervix due to the abnormal growth of cells typically caused by persistent infection with high-risk HPV types. Early detection through screenings like Cervical Screening-1 is crucial for better treatment outcomes.